CO7350654A2 - Un método para la selección de agentes que influencian los trastornos de motilidad intestinal y el dolor - Google Patents

Un método para la selección de agentes que influencian los trastornos de motilidad intestinal y el dolor

Info

Publication number
CO7350654A2
CO7350654A2 CO15068564A CO15068564A CO7350654A2 CO 7350654 A2 CO7350654 A2 CO 7350654A2 CO 15068564 A CO15068564 A CO 15068564A CO 15068564 A CO15068564 A CO 15068564A CO 7350654 A2 CO7350654 A2 CO 7350654A2
Authority
CO
Colombia
Prior art keywords
intestinal motility
selection
treatment
motility disorders
gastrointestinal
Prior art date
Application number
CO15068564A
Other languages
English (en)
Spanish (es)
Inventor
Eamonn Connolly
Wolfgang Kunze
Bienenstock John
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49115523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO7350654(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of CO7350654A2 publication Critical patent/CO7350654A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/10—Segmentation; Edge detection
    • G06T7/13—Edge detection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30092—Stomach; Gastric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Quality & Reliability (AREA)
  • Radiology & Medical Imaging (AREA)
  • Toxicology (AREA)
CO15068564A 2012-09-03 2015-03-25 Un método para la selección de agentes que influencian los trastornos de motilidad intestinal y el dolor CO7350654A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261696277P 2012-09-03 2012-09-03

Publications (1)

Publication Number Publication Date
CO7350654A2 true CO7350654A2 (es) 2015-08-10

Family

ID=49115523

Family Applications (1)

Application Number Title Priority Date Filing Date
CO15068564A CO7350654A2 (es) 2012-09-03 2015-03-25 Un método para la selección de agentes que influencian los trastornos de motilidad intestinal y el dolor

Country Status (27)

Country Link
US (5) US9555065B2 (https=)
EP (2) EP3369808A1 (https=)
JP (3) JP6259458B2 (https=)
KR (1) KR102293438B1 (https=)
CN (4) CN104918640B (https=)
AU (1) AU2013308299B2 (https=)
CA (2) CA3268968A1 (https=)
CL (2) CL2015000490A1 (https=)
CO (1) CO7350654A2 (https=)
DK (1) DK2893045T3 (https=)
ES (1) ES2681974T3 (https=)
GE (1) GEP201706775B (https=)
HK (1) HK1258778A1 (https=)
HR (1) HRP20181033T1 (https=)
IL (2) IL237397B (https=)
IN (1) IN2015DN01572A (https=)
LT (1) LT2893045T (https=)
MX (2) MX362495B (https=)
MY (2) MY182358A (https=)
NZ (1) NZ705358A (https=)
PH (1) PH12015500452B1 (https=)
RU (1) RU2701348C2 (https=)
SG (3) SG10202101556WA (https=)
SI (1) SI2893045T1 (https=)
UA (2) UA118339C2 (https=)
WO (1) WO2014033330A1 (https=)
ZA (1) ZA201501472B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12013500224A1 (en) 2010-08-04 2013-04-08 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN108094541A (zh) * 2018-01-11 2018-06-01 黑龙江完达山林海液奶有限公司 一种具有保健益生功能的风味发酵乳及其制备方法
IL305597B2 (en) 2018-07-24 2024-08-01 Biogaia Ab Selection and use of melatonin-supporting bacteria to reduce infantile tinea
EP3980289A1 (en) 2019-06-05 2022-04-13 AVL Powertrain Engineering, Inc. Vehicle frame and power supply assembly and related systems and methods
JP7394883B2 (ja) * 2019-06-05 2023-12-08 エーヴィーエル パワートレイン エンジニアリング インコーポレイテッド 車両の車軸アセンブリ
EP3980285A1 (en) 2019-06-05 2022-04-13 AVL Powertrain Engineering, Inc. Vehicle frame assembly and power supply tray
CN110186922B (zh) * 2019-06-25 2021-07-23 西安交通大学医学院第一附属医院 一种监测结肠移行性复合运动的实验装置及方法
US11843097B2 (en) 2019-09-10 2023-12-12 Avl Powertrain Engineering, Inc. Power supply control systems and methods
CN112710823B (zh) * 2020-12-17 2024-03-29 中国科学院深圳先进技术研究院 一种肠移行性复合运动的离体检测系统及其应用
CN114342878B (zh) * 2022-01-10 2022-09-30 南京鼓楼医院 一种慢传输型便秘动物模型的建立方法
CN117384804A (zh) * 2023-12-12 2024-01-12 北京三元食品股份有限公司 格氏乳杆菌b1-26及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438989A (en) * 1990-08-10 1995-08-08 Hochman; Darryl Solid tumor, cortical function, and nerve tissue imaging methods and device
IT1314185B1 (it) * 1998-08-21 2002-12-06 Novartis Ag Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
JP2003507472A (ja) * 1999-07-06 2003-02-25 エンファーマ エル．ピー． 消化管運動および食物摂取を調節するための方法ならびに組成物
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
CN1663573B (zh) * 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
US20090233888A1 (en) * 2005-03-23 2009-09-17 Usc Stevens, University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
JP5036020B2 (ja) * 2005-11-30 2012-09-26 雪印メグミルク株式会社 腎周囲脂肪蓄積抑制剤
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
JP5019563B2 (ja) * 2006-06-16 2012-09-05 旭化成ケミカルズ株式会社 腸内細菌賦活剤
CN101801200B (zh) * 2007-09-17 2014-10-29 康奈尔大学 用于预防或治疗胃肠病症的支链脂肪酸
WO2011012655A1 (en) * 2009-07-31 2011-02-03 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
US20110110905A1 (en) * 2009-11-06 2011-05-12 Ritchie Jennifer A Infant Colic Supplement
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US20120034198A1 (en) * 2010-08-04 2012-02-09 Microbios, Inc. Carriers for storage and delivery of biologics
CN102304489B (zh) * 2011-09-23 2013-06-12 北京龙科方舟生物工程技术有限公司 一株罗伊氏乳杆菌及其应用

Also Published As

Publication number Publication date
KR102293438B1 (ko) 2021-08-25
CN109966511A (zh) 2019-07-05
EP3369808A1 (en) 2018-09-05
ES2681974T3 (es) 2018-09-17
IL237397A0 (en) 2015-04-30
IL237397B (en) 2018-10-31
WO2014033330A1 (en) 2014-03-06
KR20150048201A (ko) 2015-05-06
NZ705358A (en) 2018-09-28
CL2015000490A1 (es) 2015-05-29
AU2013308299A1 (en) 2015-03-26
MX2018013097A (es) 2020-09-02
US20170114422A1 (en) 2017-04-27
JP2018090616A (ja) 2018-06-14
MX2015002792A (es) 2015-05-07
US10174388B2 (en) 2019-01-08
IN2015DN01572A (https=) 2015-07-03
JP2015529329A (ja) 2015-10-05
RU2701348C2 (ru) 2019-09-26
PH12015500452A1 (en) 2015-04-20
MY182358A (en) 2021-01-20
CL2017002826A1 (es) 2018-04-06
MY195532A (en) 2023-01-31
CN104918640A (zh) 2015-09-16
DK2893045T3 (en) 2018-07-30
SG11201501297TA (en) 2015-03-30
EP2893045B1 (en) 2018-05-16
CN108904545A (zh) 2018-11-30
JP6259458B2 (ja) 2018-01-10
JP2018029588A (ja) 2018-03-01
EP2893045A1 (en) 2015-07-15
US20190112676A1 (en) 2019-04-18
UA126374C2 (uk) 2022-09-28
US9816150B2 (en) 2017-11-14
US9555065B2 (en) 2017-01-31
SI2893045T1 (en) 2018-08-31
AU2013308299B2 (en) 2019-04-18
SG10202101556WA (en) 2021-03-30
CN108753645A (zh) 2018-11-06
GEP201706775B (en) 2017-11-27
IL259652A (en) 2018-07-31
CA3268968A1 (en) 2025-11-29
LT2893045T (lt) 2018-07-25
RU2015112102A (ru) 2016-10-20
CA2883440A1 (en) 2014-03-06
HK1258774A1 (zh) 2019-11-22
JP6476328B2 (ja) 2019-02-27
HRP20181033T1 (hr) 2018-08-24
SG10201608055XA (en) 2016-11-29
MX362495B (es) 2019-01-21
ZA201501472B (en) 2016-06-29
HK1258778A1 (zh) 2019-11-22
HK1211848A1 (en) 2016-06-03
US20180023150A1 (en) 2018-01-25
CN104918640B (zh) 2019-03-19
CN108753645B (zh) 2019-10-22
US20220306984A1 (en) 2022-09-29
PH12015500452B1 (en) 2023-01-20
UA118339C2 (uk) 2019-01-10
IL259652B (en) 2020-03-31
JP6322326B2 (ja) 2018-05-09
US20150231186A1 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
CO7350654A2 (es) Un método para la selección de agentes que influencian los trastornos de motilidad intestinal y el dolor
MX2020008976A (es) Biomarcadores y su uso en el tratamiento de condiciones relacionadas con pd-1 y pd-l1.
MX377877B (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
EA201600191A1 (ru) Фармацевтические композиции, содержащие диастереомеры макролида, способы их синтезирования и терапевтическое применение
CR20150638A (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos
MX2018003699A (es) Moduladores de tlr y metodos de uso.
EP4066264A4 (en) System and method for virtual reality based human biological metrics collection and stimulus presentation
ZHAO et al. Clinical study on needling LIN’s three temporal acupoints for children with autism
Kozlovskiy et al. Selective involvement of lingual gyrus in working memory and perception of different types of visual stimuli
MAO et al. Impact of Stimulation Parameters on Event-related Potential P300
Yang et al. Practice of “one week with one case” teaching method with college-enterprise cooperation in the theoretical classes of contact lens courses
Park et al. Effect of the brotherhood group sensory integration intervention to social interaction of the children with pervasive developmental disorders
WANG et al. Effect of needle warming moxibustion on cognitive dysfunction after stroke
RU2014152400A (ru) Способ компьютерного совмещения изображений для топохимического картирования нейронов центральной нервной системы
Park et al. A FUNCTIONAL MAGNETIC RESONANCE IMAGING STUDY ON THE EFFECTS OF JAW-TAPPING MOVEMENT ON MEMORY FUNCTION IN ELDERLY PEOPLE WITH MEMORY DISTURBANCE
HUA et al. Gait disorders research in Alzheimer's disease
ZHU et al. Effect of neuromuscular electrical stimulation and swallowing training on dysphasia after stroke
Lutfullaeva Improvement of Language Skillsat English Lessons
Aziz et al. Applied exercise education for increasing daily physical actıvity
RU2013126763A (ru) Способ диагностики прогностически опасных форм периферических дистрофий сетчатки
Lee et al. The Processing of Humor Advertisement: Evidence from Eye Movement
Greenberg Rejuvenating psychotherapy: Science battles business.
Dantas et al. Effects of neuromuscular electrical stimulation and resistance training on skeletal muscle responses of elderly people
RU2012118277A (ru) Способ тренировки периодонто-мышечного комплекса жевательного аппарата
UA76081U (uk) Спосіб оцінки генуїнної тривожності людини